Related Experiment Video
Updated: Jul 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Missed targets: gender differences in the identification and management of dyslipidemia
1The Heart Group, Lancaster, Pa, USA. K_Trynosky@hotmail.com
Abstract:
Gender differences in the treatment of heart disease have a significant impact on the outcomes and mortality for women. From screening and detection, through treatment and intervention, women are less likely than men to receive guideline-based care. Risk factor modification, including lipid management, is critical to all levels of prevention. This article discusses gender differences in the detection and management of dyslipidemia. By identifying the suboptimal recognition and treatment of lipid abnormalities in women, healthcare professionals can revise their practice patterns in an effort to improve the outcomes for women with cardiovascular disease.
Related Concept Videos
Atherosclerosis III: Management
Pharmacogenomics: Identification of New Drug Targets
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Panic Disorder
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures